Knowledge Graphs and Explainable AI for Drug Repurposing on Rare Diseases
Perdomo-Quinteiro, P.; Wolstencroft, K.; Roos, M.; Queralt-Rosinach, N.
Show abstract
Artificial Intelligence (AI)-based drug repurposing is an emerging strategy to identify drug candidates to treat rare diseases. However, cutting-edge algorithms based on Deep Learning (DL) typically dont provide a human understandable explanation supporting their predictions. This is a problem because it hampers the biologists ability to decide which predictions are the most plausible drug candidates to test in costly lab experiments. In this study, we propose rd-explainer a novel AI drug repurposing method for rare diseases which obtains possible drug candidates together with human understandable explanations. The method is based on Graph Neural Network (GNN) technology and explanations were generated as semantic graphs using state-of-the-art eXplainable AI (XAI). The model learns features from current background knowledge on the target rare disease structured as a Knowledge Graph (KG), which integrates curated facts and their evidence on different biomedical entities such as symptoms, drugs, genes and ortholog genes. Our experiments demonstrate that our method has excellent performance that is superior to state-of-the-art models. We investigated the application of XAI on drug repurposing for rare diseases and we prove our method is capable of discovering plausible drug candidates based on testable explanations. The data and code are publicly available at https://github.com/PPerdomoQ/rare-disease-explainer. HighlightsO_LIWe demonstrated the use of graph-based explainable AI for drug repurposing on rare diseases to accelerate sound discovery of new therapies for this underrepresented group. C_LIO_LIWe developed rd-explainer for rare disease specific drug research for faster translation. It predicts drugs to treat symptoms/phenotypes, it is highly performant and novel candidates are plausible according to evidence in the scientific literature and clinical trials. Key is that it learns a GNN model that is trained on a knowledge graph built specifically for a rare disease. We provide rd-explainer code freely available for the community. C_LIO_LIrd-explainer is researcher-centric interpretable ML for hypothesis generation and lab-in-the-loop drug research. Explanations of predictions are semantic graphs in line with human reasoning. C_LIO_LIWe detected an effect of knowledge graph topology on explainability. This highlights the importance of knowledge representation for the drug repurposing task. C_LI
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- A Graph-Attention-Based Deep Learning Network for Predicting Biotech-Small-Molecule Drug Interactions 97%
- Mining drug-target interactions from biomedical literature using chemical and gene descriptions-based ensemble transformer model. 96%
- SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing 95%
Similar papers in this journal
Similar papers in this journal
- Employing Machine Learning Techniques to Detect Protein-Protein Interaction: A Survey, Experimental, and Comparative Evaluations 93%
- AE-LGBM: Sequence-Based Novel Approach To Detect Interacting Protein Pairs via Ensemble of Autoencoder and LightGBM. 93%
- Alzheimer Disease Knowledge Graph Enhances Knowledge Discovery and Disease Prediction 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.